Health & Biotech
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on Opthea.
RELATED STOCKHEAD STORIES
Health & Biotech
Health Check: It’s a small world after all for global microcap index additions LTR Pharma and EZZ Life Science
Health & Biotech
Health Check: Medical pot play Cann Group sees an earnings turnaround through the haze
News
Market Highlights: Wall Street spooked after Powell warns not to get too excited; and 5 small caps to watch
News
ASX Rebalance: Copper in, lithium out as hot biotechs climb ranks
Health & Biotech
Alive and Kicking: ‘We are not alone in going through a lull in markets’, says Clinuvel chair
Health & Biotech
Bio Curious: How Dimerix negotiates the ‘valleys of death’ on the winding road to drug approval
Investor Guides
Investor Guide: Health & Biotech FY2025 featuring Tim Boreham
News
Closing Bell: Local tech talent steps up ahead of blockbuster inflation week
News
Rise and Shine: Everything you need to know before the ASX opens
News
Rise and Shine: Everything you need to know before the ASX opens
Health & Biotech
ASX Health Stocks: PainChek wins European patent; Phase 3 Trial set to begin for Opthea
Health & Biotech
End in sight as Opthea looks to be key player in US$10 billion wet AMD market
Health & Biotech
ASX Health Stocks: Clarity’s imaging agent can identify prostate cancer lesions at double the rate
News
Market Highlights: Meta surges 14pc, uranium stocks most traded by Aussies, and 5 small caps to watch today
News
In Case You Missed It: Drilling deals, niobium and a Peruvian project
Health & Biotech
ASX Health Stocks: Opthea up 13pc on $85m funding from giant investment firm Carlyle, new investor
News
